Apollo Global Management (APO) is up 3.1% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver appears to be growing optimism ahead of Apollo’s August 4, 2026 second-quarter earnings report, supported by the company’s earlier preliminary investment-income update for the quarter. No fresh company-specific announcement appears to fully explain the move today, so part of the gain could also reflect positioning and technical trading.
Details:
Sources:
Apollo Global Management, SEC
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$APO Insider Trading Activity
$APO insiders have traded $APO stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $APO stock by insiders over the last 6 months:
- JOHN P. ZITO (Co-President (see Remarks)) has made 0 purchases and 3 sales selling 48,644 shares for an estimated $6,355,707.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$APO Hedge Fund Activity
We have seen 530 institutional investors add shares of $APO stock to their portfolio, and 550 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS added 15,179,699 shares (+138.0%) to their portfolio in Q1 2026, for an estimated $1,691,322,062
- FMR LLC removed 8,492,963 shares (-27.9%) from their portfolio in Q1 2026, for an estimated $946,285,937
- CAPITAL WORLD INVESTORS removed 5,262,741 shares (-21.8%) from their portfolio in Q1 2026, for an estimated $586,374,602
- UBS GROUP AG added 2,802,815 shares (+77.0%) to their portfolio in Q1 2026, for an estimated $312,289,647
- MARINER, LLC added 2,212,351 shares (+90.9%) to their portfolio in Q1 2026, for an estimated $246,500,148
- CLEARBRIDGE INVESTMENTS, LLC added 2,024,048 shares (+64.2%) to their portfolio in Q1 2026, for an estimated $225,519,428
- FOCUS PARTNERS WEALTH added 1,849,786 shares (+131.7%) to their portfolio in Q1 2026, for an estimated $206,103,156
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$APO Congressional Stock Trading
Members of Congress have traded $APO stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $APO stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 04/14 and 1 sale worth up to $15,000 on 03/13.
- SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$APO Price Targets
Multiple analysts have issued price targets for $APO recently. We have seen 11 analysts offer price targets for $APO in the last 6 months, with a median target of $146.0.
Here are some recent targets:
- Benjamin Budish from Barclays set a target price of $132.0 on 07/09/2026
- Crispin Love from Piper Sandler set a target price of $157.0 on 05/26/2026
- Bill Katz from TD Cowen set a target price of $146.0 on 05/18/2026
- Michael Brown from UBS set a target price of $158.0 on 05/08/2026
- Bart Dziarski from RBC Capital set a target price of $146.0 on 05/07/2026
- Glenn Schorr from Evercore ISI Group set a target price of $145.0 on 04/21/2026
- Michael Cyprys from Morgan Stanley set a target price of $165.0 on 04/21/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.